Provider resources • Clinical review drafts · Secure submission coming soon
Adara Specialty Pharmacy
← Back to Adara

FOR REFERRING PROVIDERS

Less searching.
A clearer referral.

Find the right starting point for your patient’s specialty therapy. Download a fillable form with clinical documentation and authorization review checklists.

Prepared for clinical review. Secure referrals are not open yet.

This is a starter library, not a ranked drug list or confirmation of Adara’s product access. Review and approve each form before clinical use. Completed forms must go through Adara’s confirmed secure referral channel once available—this website does not collect patient records.

Showing 25 forms

Routine antibiotic infusions and TPN are outside our scope.
Immunoglobulin

IVIG

Intravenous immunoglobulin

ExamplesPrivigen, Gamunex-C, Gammagard, Panzyga

Clinical documentation checklist
  • Specialist note identifying the exact diagnosis, severity, treatment goal and requested product.
  • For antibody deficiency: pretreatment IgG/IgA/IgM, vaccine-response results and infection history, as applicable.
  • For neurologic / other indications: diagnosis-specific testing, functional scores and prior treatment outcomes.
  • Previous IG product, regimen, tolerance and dated weight; any product-specific supporting records.
  • Renewal: objective response, infection frequency or functional change, current dose and continued need.

Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗

3 pages · Fillable · DraftDownload form
Immunoglobulin

SCIG

Subcutaneous immunoglobulin

ExamplesHizentra, Cuvitru, Xembify, HyQvia

Clinical documentation checklist
  • Diagnosis and specialist assessment supporting the requested SCIG product and indication.
  • For antibody deficiency: pretreatment immunoglobulins, antibody response and infection history, as applicable.
  • For other indications: diagnostic evidence and prior therapy records required by the exact product / plan.
  • Current IG dose, dates, response and reason for change; administration / training plan and dated weight.
  • Renewal: infection or functional outcomes, adherence, tolerance and continuing clinical need.

Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗

3 pages · Fillable · DraftDownload form
Rare disease & other

Alpha-1 augmentation

Alpha-1 proteinase inhibitor

ExamplesProlastin-C, Glassia, Zemaira, Aralast NP

Clinical documentation checklist
  • Specialist documentation of AAT deficiency and relevant lung disease; exact augmentation product.
  • Pretreatment serum alpha-1 antitrypsin level with units and lab method, plus phenotype / genotype.
  • Pulmonary function report including post-bronchodilator FEV1; supporting imaging when requested.
  • Dated weight, previous augmentation regimen and smoking history / cessation documentation as applicable.
  • Renewal: documented clinical benefit, adherence, tolerance and current treatment plan.

Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗

3 pages · Fillable · DraftDownload form
Autoimmune & GI

Infliximab

Infliximab products

ExamplesRemicade, Inflectra, Renflexis, Avsola, Zymfentra

Clinical documentation checklist
  • Diagnosis-specific specialist notes: disease activity, severity and relevant examination findings.
  • Objective evidence for the indication: GI studies, joint assessments or skin involvement, as applicable.
  • Prior conventional / biologic treatments: drug, dose, dates, outcome, intolerance or contraindication.
  • Exact product / route, induction history, current weight and clinician-required screening records.
  • Renewal: documented response; clinical rationale and supporting records for any dose / interval change.

Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗

3 pages · Fillable · DraftDownload form
Autoimmune & GI

Vedolizumab

Vedolizumab

ExamplesEntyvio

Clinical documentation checklist
  • Gastroenterology notes with diagnosis, activity, symptoms and clinical reason for therapy.
  • Available endoscopy / pathology, imaging and inflammatory markers supporting the GI diagnosis.
  • Prior treatments and response, dated trials, intolerance / contraindication, and steroid dependence if relevant.
  • Exact IV or SC formulation, induction dates and maintenance plan; current therapy / screening records.
  • Renewal: symptom / objective improvement, steroid use and rationale for continued treatment.

Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗

3 pages · Fillable · DraftDownload form
Autoimmune & GI

Ustekinumab

Ustekinumab products

ExamplesStelara and biosimilars

Clinical documentation checklist
  • Specialist note identifying the indication, severity and exact requested product / formulation.
  • GI: diagnostic studies and activity; skin: body areas / severity; joint disease: clinical activity, as applicable.
  • Previous therapies with doses, dates, outcomes and reasons preferred alternatives are unsuitable.
  • Induction versus maintenance history, dated weight and clinician-required pretreatment screening.
  • Renewal: improvement in the relevant disease measures and continued need for the prescribed regimen.

Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗

3 pages · Fillable · DraftDownload form
Autoimmune & GI

Risankizumab

Risankizumab-rzaa

ExamplesSkyrizi

Clinical documentation checklist
  • Specialist diagnosis, disease activity and exact indication for the requested formulation.
  • GI studies, skin severity / affected areas, or joint findings relevant to the patient's indication.
  • Prior systemic / biologic treatments with dates, response, intolerance or contraindication.
  • Induction and maintenance plan; screening and monitoring documentation required for the indication.
  • Renewal: objective or symptom response, current regimen and explanation of requested changes.

Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗

3 pages · Fillable · DraftDownload form
Autoimmune & GI

Abatacept

Abatacept

ExamplesOrencia

Clinical documentation checklist
  • Rheumatology / relevant specialist assessment documenting diagnosis, activity and clinical severity.
  • Indication-specific objective support: joint findings, disease activity measures and diagnostic labs.
  • Previous DMARD / biologic trials with dose, dates, response and contraindications or intolerance.
  • Exact IV or SC formulation, current weight if relevant, concomitant medications and required screening.
  • Renewal: documented disease improvement, tolerability and continuing treatment plan.

Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗

3 pages · Fillable · DraftDownload form
Autoimmune & GI

Tocilizumab

Tocilizumab products

ExamplesActemra and biosimilars

Clinical documentation checklist
  • Specialist notes specifying the exact indication and severity; requested product and route.
  • Indication-specific diagnostic evidence and baseline disease activity / inflammatory findings.
  • Previous therapies, adequate trial dates and outcomes; reasons alternatives are inappropriate.
  • Prescriber-directed screening / monitoring records, such as TB, blood counts and liver tests, as applicable.
  • Renewal: clinical response, current regimen, concomitant therapies and relevant monitoring results.

Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗

3 pages · Fillable · DraftDownload form
Autoimmune & GI

Rituximab

Rituximab products

ExamplesRituxan, Ruxience, Truxima, Riabni

Clinical documentation checklist
  • Specialist notes confirming the exact indication, clinical severity and requested product.
  • Indication-specific diagnostic reports and baseline disease measures supporting medical necessity.
  • Previous treatments, dose / duration / response; previous rituximab courses and reason for retreatment.
  • Clinician-required screening, including hepatitis B records where applicable, and prescribed monitoring.
  • Renewal: objective treatment response, course dates, tolerance and rationale for another course.

Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗

3 pages · Fillable · DraftDownload form
Autoimmune & GI

Belimumab

Belimumab

ExamplesBenlysta

Clinical documentation checklist
  • Specialist confirmation of the lupus indication, activity and relevant organ involvement.
  • Autoantibody results and disease activity documentation; renal studies for nephritis when applicable.
  • Current standard therapy and prior treatment trials, with dates, response or contraindication.
  • Requested IV or SC product, clinical reason for therapy and prescriber-required safety records.
  • Renewal: improvement in lupus activity / relevant organ measures and continuing standard therapy.

Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗

3 pages · Fillable · DraftDownload form
Autoimmune & GI

Anifrolumab

Anifrolumab-fnia

ExamplesSaphnelo

Clinical documentation checklist
  • Rheumatology assessment documenting active SLE, severity and organ involvement.
  • Autoantibody / diagnostic results and a baseline disease activity assessment, as required by the plan.
  • Current standard lupus therapy and prior trials with response, intolerance or contraindications.
  • Exact formulation; relevant infection / safety assessment and concomitant medication record.
  • Renewal: change in disease activity, symptoms or steroid use and documented continued clinical benefit.

Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗

3 pages · Fillable · DraftDownload form
Autoimmune & GI

Golimumab

Golimumab

ExamplesSimponi, Simponi Aria

Clinical documentation checklist
  • Specialist diagnosis and severity; specify Simponi versus Simponi Aria and the intended route.
  • Disease-specific evidence, such as joint findings, diagnostic labs or GI studies, as applicable.
  • Prior DMARD / biologic trials and concomitant therapy; dose, duration, outcomes and contraindications.
  • Prescriber-required screening and dated weight when relevant; initial versus maintenance regimen.
  • Renewal: clinical response, tolerance and rationale for ongoing therapy or regimen changes.

Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗

3 pages · Fillable · DraftDownload form
Neurology

Ocrelizumab

Ocrelizumab-based products

ExamplesOcrevus, Ocrevus Zunovo

Clinical documentation checklist
  • Neurologist assessment specifying MS subtype, course and relevant functional / relapse history.
  • Diagnostic records, including MRI findings and other support for the MS diagnosis when requested.
  • Prior disease-modifying therapies, dates, response and reasons for discontinuation / transition.
  • Exact formulation, last treatment date and clinician-required screening / vaccination documentation.
  • Renewal: disease activity / functional change, current treatment response and medication reconciliation.

Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗

3 pages · Fillable · DraftDownload form
Neurology

Natalizumab

Natalizumab products

ExamplesTysabri, Tyruko

Clinical documentation checklist
  • Specialist note specifying the indication, disease activity and exact natalizumab product.
  • Indication-specific diagnostics (MS or GI), prior therapies and documented response / intolerance.
  • Applicable product program / REMS enrollment documentation and authorized administration arrangements.
  • Prescriber risk assessment and monitoring records, including JCV-related records when applicable.
  • Renewal: response, treatment dates, concomitant medication review and current program requirements.

Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗

3 pages · Fillable · DraftDownload form
Neurology

Efgartigimod

Efgartigimod-based products

ExamplesVyvgart, Vyvgart Hytrulo

Clinical documentation checklist
  • Neurologist diagnosis, exact product / route and the indication-specific treatment rationale.
  • gMG: baseline severity / MG-ADL and antibody records as requested; verify current product / plan criteria.
  • CIDP, when applicable: diagnostic / electrodiagnostic support and baseline functional measures.
  • Previous therapies with dates / outcomes, current regimen and clinician-directed safety records.
  • Renewal: comparable symptom / functional scores, response by cycle and rationale for continued use.

Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗

3 pages · Fillable · DraftDownload form
Rare disease & other

Ravulizumab

Ravulizumab-cwvz

ExamplesUltomiris

Clinical documentation checklist
  • Specialist note identifying the exact indication, severity and reason for complement-inhibitor treatment.
  • Indication-specific support: PNH flow cytometry / hemolysis; aHUS workup; or relevant neurologic antibodies.
  • Previous treatments, current weight, last complement-inhibitor dose and transition / maintenance plan.
  • Applicable REMS / enrollment, meningococcal vaccination and prescriber-directed prevention records.
  • Renewal: indication-specific response (labs, organ function or clinical scores) and continued need.

Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗

3 pages · Fillable · DraftDownload form
Rare disease & other

Eculizumab

Eculizumab products

ExamplesSoliris and biosimilars

Clinical documentation checklist
  • Specialist diagnosis, exact product and documented disease severity / medical necessity.
  • Diagnosis-specific evidence: PNH testing; aHUS workup; or neurologic diagnostic / antibody records.
  • Previous therapies with dated outcomes, current weight and prior complement-inhibitor treatment.
  • Applicable product REMS / enrollment, meningococcal vaccination and prevention documentation.
  • Renewal: objective response, current dosing history and ongoing clinical need for the exact product.

Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗

3 pages · Fillable · DraftDownload form
Neurology

Edaravone

Edaravone products

ExamplesEdaravone injection, Radicava ORS

Clinical documentation checklist
  • ALS specialist / neurologist assessment and diagnostic evidence supporting definite or probable ALS.
  • Baseline ALSFRS-R with dated item scores; respiratory / ventilatory status and requested supporting tests.
  • Clinical history and prior / current ALS treatments with dates, response and tolerance.
  • Exact formulation and route; prescribed cycle, last treatment dates and administration needs.
  • Renewal: clinical benefit, functional / respiratory status and continuing plan; verify route-specific policy.

Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗

3 pages · Fillable · DraftDownload form
Neurology

Eptinezumab

Eptinezumab-jjmr

ExamplesVyepti

Clinical documentation checklist
  • Migraine diagnosis with baseline headache days and migraine days per month, supported by dated records.
  • Prior preventive medicines: dose, trial duration, response, intolerance or contraindication.
  • Current preventive and acute medications; prior CGRP / botulinum therapy and transition plan if relevant.
  • Prescriber assessment of functional burden and reason for requested product / regimen.
  • Renewal: change in migraine frequency or severity and documented benefit compared with baseline.

Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗

3 pages · Fillable · DraftDownload form
Rare disease & other

Teprotumumab

Teprotumumab-trbw

ExamplesTepezza

Clinical documentation checklist
  • Specialist TED diagnosis and activity / severity assessment; document chronic or active disease.
  • Eye findings: proptosis, diplopia, soft-tissue changes or clinical activity score, as applicable.
  • Thyroid function / management and prior TED treatments; number and dates of previous infusions.
  • Prescriber-directed baseline / monitoring records, including hearing and glucose assessment as applicable.
  • Continuation: treatment response and planned remaining course; verify payer lifetime / retreatment limits.

Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗

3 pages · Fillable · DraftDownload form
Autoimmune & GI

Pegloticase

Pegloticase

ExamplesKrystexxa

Clinical documentation checklist
  • Chronic refractory gout diagnosis with flares, tophi or gout-related joint damage documented.
  • Dated serum urate results and prior urate-lowering trials with doses, duration and response / intolerance.
  • Prescriber safety records, including G6PD status where applicable, and planned monitoring.
  • Concomitant immunomodulator plan or clinical reason for omission; previous pegloticase dates.
  • Renewal: serum urate trend, clinical response, tolerance and continued treatment rationale.

Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗

3 pages · Fillable · DraftDownload form
Allergy & asthma

Omalizumab

Omalizumab

ExamplesXolair

Clinical documentation checklist
  • Specialist diagnosis and indication-specific severity; verify the exact product / formulation.
  • For asthma / polyps / food allergy: IgE, weight and diagnostic testing as applicable to the indication.
  • For urticaria: symptom duration / severity and prior antihistamine trials; other indications use their criteria.
  • Prior / current therapies, dates and outcomes; exacerbation history or allergic-event history as relevant.
  • Renewal: indication-specific improvement, adherence and continued need; administration plan documented.

Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗

3 pages · Fillable · DraftDownload form
Allergy & asthma

Dupilumab

Dupilumab

ExamplesDupixent

Clinical documentation checklist
  • Specialist documentation of the exact indication, severity and requested device / formulation.
  • For dermatitis: affected body areas, severity / functional burden and prior topical / systemic treatments.
  • For other indications: obtain the current payer criteria and diagnosis-specific studies / clinical measures.
  • Previous therapy doses, durations, response and reasons alternatives are unsuitable; current therapy list.
  • Renewal: indication-specific improvement and continued need; dose and device match the patient / order.

Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗

3 pages · Fillable · DraftDownload form
Allergy & asthma

Mepolizumab

Mepolizumab

ExamplesNucala

Clinical documentation checklist
  • Specialist diagnosis and severity; specify the indication and exact product / device.
  • For eosinophilic asthma: dated eosinophil counts, exacerbations, steroid use and controller regimen.
  • For other indications: diagnosis-specific evidence (e.g., nasal findings, EGPA / HES workup) per payer policy.
  • Previous therapies, doses, dates and outcomes; current medications and required exclusion workup.
  • Renewal: clinical improvement, exacerbation / steroid trend or other indication-specific response.

Documentation prompts, not universal criteria. Match the exact indication, product and member’s plan. Example payer policy ↗

3 pages · Fillable · DraftDownload form

A MORE COMPLETE REFERRAL

The right records.
Fewer avoidable delays.

Each three-page form includes patient and coverage details, the therapy request, a clinical records checklist, and an authorization and billing review.

  1. Prepare the clinical recordInclude the diagnosis, prior treatments and the therapy-specific supporting records requested by the patient’s plan.
  2. Verify authorization and benefitsConfirm the exact product, route, dose, units, dates, provider identifiers and approved site of care.
  3. Check the claim requirementsReview sourcing, payment terms, coding, unit conversions and required delivery or administration documentation.

Prior authorization does not guarantee payment. Requirements vary by payer, benefit, indication and product. These drafts are not prescriptions, treatment protocols, or a complete safety checklist. Policy examples are linked in each form; verify the current member-specific requirements.

Open downloaded files in a PDF reader that supports fillable fields. Save your completed copy locally. No form automatically emails or uploads its contents.